Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer
Dietlein, M.; Dressler, J.; Farahati, J.; Leisner, B.; Moser, E.; Reiners, C.; Schicha, H.; Schober, O.
Nuklearmedizin. Nuclear Medicine 38(6a): 221-222
1999
ISSN/ISBN: 0029-5566 PMID: 10510812 Document Number: 502882
Document emailed within 1 workday
Related Documents
Salvatori, M.; Rufini, V.; Garganese, M.C.; Di Giuda, D. 2000: Radioiodine therapy in differentiated thyroid carcinoma Rays 25(2): 221-238Zakani, A.; Saghari, M.; Eftekhari, M.; Fard-Esfahani, A.; Fallahi, B.; Esmaili, J.; Assadi, M. 2011: Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131i with emphasize on the thallium scintigraphy in these subgroups European Review for Medical and Pharmacological Sciences 15(10): 1215-1221
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Saengsuda, Y. 2013: Radioiodine remnant ablation in low-risk differentiated thyroid cancer Journal of the Medical Association of Thailand 96(5): 614-624
Hodak, S.P.; Carty, S.E. 2009: Radioiodine-resistant differentiated thyroid cancer: hope for the future Oncology 23(9): 775-776
Claimon, A.; Pusuwan, P.; Khiewvan, B. 2017: Factors Influencing the Success of the first Radioiodine Therapy for Differentiated Thyroid Carcinoma Journal of the Medical Association of Thailand 100(2): 207-218
Hasse-Lazar, K.; Handkiewicz-Junak, D.; Roskosz, Józef.; Szpak-Ulczok, S.; Krajewska, J.; Jurecka-Lubieniecka, B.; Jarzab, B. 2006: Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences Endokrynologia Polska 57(4): 445-450
Sriprapaporn, J.; Sethanandha, C.; Yingsa-nga, T.; Komoltri, C.; Thongpraparn, T.; Harnnanthawiwai, C. 2015: Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer Journal of the Medical Association of Thailand 98(6): 596-605
Kusić, Z.; Jukić, T.; Dabelić, N.; Franceschi, M. 2008: Croatian Thyroid Society guidelines for the management of patients with differentiated thyroid cancer Lijecnicki vjesnik 130(9-10): 213-227
Bałdys-Waligórska, A.; Gołkowski, F.; Krzentowska-Korek, A.; Hubalewska-Dydejczyk, A. 2010: Radioiodine ablation of thyroid remnants in patients with differentiated thyroid carcinoma (DTC) following administration of rhTSH - a comparison with L-thyroxine withdrawal Endokrynologia Polska 61(5): 474-479
Ahn, B-Cheol. 2013: Radioiodine SPET/CT guided needle aspiration as a useful technique for recurrence surveillance in a thyroidectomized differentiated thyroid cancer patient with negative US and serum Tg and positive Tg of the lymph node aspirate Hellenic Journal of Nuclear Medicine 16(2): 142-143
Horácek, Jí. 2015: Radioiodine therapy in patients with low-thyroid cancer Vnitrni Lekarstvi 61(9): 755-757
Konrády, Aás. 2002: Radioiodine treatment of differentiated thyroid carcinomas: residual ablation Orvosi Hetilap 143(25): 1557; Author Reply
Schiavo, M.; Bagnara, M.C.; Pomposelli, E.; Altrinetti, V.; Calamia, I.; Camerieri, L.; Giusti, M.; Pesce, G.; Reitano, C.; Bagnasco, M.; Caputo, M. 2013: Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 301-307
Ronga, G.; Toteda, M.; D'Apollo, R.; De Cristofaro, F.; Filesi, M.; Acqualagna, G.; Argirò, R.; Ciancamerla, M.; Ugolini, F.; Montesano, T. 2012: Lymph node metastases from differentiated thyroid carcinoma: does radioiodine still play a role? La Clinica Terapeutica 163(5): 377-381
Markou, P.; Chatzopoulos, D. 2004: Isolation period prediction in patients with differentiated thyroid carcinoma treated after thyroidectomy by radioiodine-131 Hellenic Journal of Nuclear Medicine 7(3): 195-198
Einhorn, J. 1977: Radiation therapy of differentiated thyroid cancer Lakartidningen 74(35): 2893-2896
Grudeva-Popova, J.; Yaneva, M.; Zisov, K.; Ananoshtev, N. 2007: Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 129-132
Ursu, H.I.; Dumitriu, L.; Grigorie, D.; Simescu, M.; Vaida, E.; Belgun, M.; Popovici, D. 1993: Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease) Romanian Journal of Endocrinology 31(3-4): 155-163
Ceccarelli, C.; Bencivelli, W.; Morciano, D.; Pinchera, A.; Pacini, F. 2001: 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study Journal of Clinical Endocrinology and Metabolism 86(8): 3512-3515